Many investigations have been carried out to modulate this immune reaction in order to improve keratoplasty results, including prevention of further angiogenesis.4,5 Many molecular factors have been identified in different studies, that can be important elements in angiogenesis.6 One of the factors identified related to neovascularization is Vascular endothelial growth factor (VEGF).4 Many VEGF inhibitors have been identified and are used for many retinal disorders,7 one of such VEGEF inhibitor is Bevacizumab. Here, VEGFA is linked to retinal disorder.